A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia

Tissue Antigens

Volumn 65, Issue 3, 2005, Pages 252-259

  Arnheim, L ^a,b   Dillner, J ^b,c   Sanjeevi, C B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

CIN; Genotype; HPV; KIR

Indexed keywords

IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOLYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFECTION CONTROL; KIR GENE; KIR2DL1 GENE; KIR2DL2 GENE; KIR2DL3 GENE; KIR2DL4 GENE; KIR2DS4 GENE; KIR3DL1 GENE; KIR3DL2 GENE; KIR3DL3 GENE; NATURAL KILLER CELL; ONCOGENE; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC SCREENING; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; POPULATION; RECEPTORS, IMMUNOLOGIC; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMA VIRUS; PAPILLOMAVIRUS;

EID: 14844310289     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00359.x     Document Type: Article

References (38)

1. IARC. Human Papilloma Viruses 1995: 64: 277-82.
2. Ghaderi M, Wallin K-L, Wiklund F et al. Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes. Int J Cancer 2002: 100: 698-701.
3. Sanjeevi CB, Hjelmstrom P, Hallmans G et al. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 1996: 68: 409-14.
4. Apple RJ, Erlich HA, Klitz W, Manos MM, Backer TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994: 6: 157-62.
5. Konya J, Dillner J. Immunity to oncogenic human papillomaviruses. Adv Cancer Res 2001: 82: 205-38.
6. Beskow AH, Josefsson AM, Gyllensten UB. HLA class II alleles associated with infection by HPV 16 in cervical cancer in situ. Int J Cancer 2001: 93: 817-22.
7. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991: 352: 723-5.
8. Wang SS, Wheeler CM, Hildesheim A et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 2001: 184: 1310-4.
9. Baxter AG, Smyth MJ. The role of NK cells in autoimmune disease. Autoimmunity 2002: 35: 1-14.
10. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002: 3: 6-8.
11. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001: 19: 291-330.
12. Lanier LL. On guard - activating NK cell receptors. Nat Immunol 2001: 2: 23-7.
13. Seliger B, Abken H, Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol 2003: 24: 82-7.
14. Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ. The genomic context of natural killer receptor extended gene families. Immunol Rev 2001: 181: 20-38.
15. Andre P, Biassoni R, Colonna M et al. New nomenclature for MHC receptors. Nat Immunol 2001: 2: 661.
16. Bruhns P, Marchetti P, Fridman WH, Vivier E, Daeron M. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. J Immunol 1999: 162: 3168-75.
17. Lanier LL. NK cell receptors. Annu Rev Immunol 1998: 16: 359-93.
18. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002: 20: 217-51.
19. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population. KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002: 54: 221-9.
20. Marsh SGE, Parham P, Dupont B et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Eur J Immunogenet 2003: 30: 229-34.
21. Martin MP, Gao X, Lee JH et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002: 31: 429-34.
22. Flores-Villanueva PO, Yunis EJ, Delgado JC et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA 2001: 98: 5140-5.
23. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington CV. Cutting edge: heterozygote advantage in autoimmune disease. Hierarchy of protection and susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004: 173: 4273-6.
24. van der Slik AR. Disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003: 52: 2639-42.
25. Chua KL, Wiklund F, Lenner P et al. A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears. Int J Cancer 1996: 68: 54-9.
26. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997: 7: 753-63.
27. Vilches C, Gardiner CM, Parham P. Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol 2000; 165: 6416-21.
28. Heino P, Dillner J, Schwartz S. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles. Virology 1995: 214: 349-59.
29. Ghaderi M, Hjelmstrom P, Hallmans G et al. MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia. Hum Immunol 1999: 60: 970-3.
30. Ghaderi M, Nikitina Zake L, Wallin K et al. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum Immunol 2001: 62: 1153-8.
31. Gomez-Lozano N, Vilches C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 2002: 59: 184-93.
32. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C. Killer-cell immunoglobulin-like receptor gene haplotypes contain between zero and two KIR2DL5 loci. Eur J Immunogenet 2001: 28: 284.
33. Yawata M, Yawata N, McQueen KL et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 2002: 54: 543-50.
34. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002: 169: 5118-29.
35. Norman PJ, Carrington CV, Byng M et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002: 3: 86-95.
36. Rajalingam R, Krausa P, Shilling HG et al. Distinctive KIR and HLA diversity in a panel of north Indian Hindus. Immunogenetics 2002: 53: 1009-19.
37. Shilling HG, Young N, Guethlein LA et al. Genetic control of human NK cell repertoire. J Immunol 2002: 169: 239-47.
38. Wang SS, Hildesheim A, Gao X et al. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 2002: 186: 598-605.